139 related articles for article (PubMed ID: 10460170)
1. WIN 17317-3, a new high-affinity probe for voltage-gated sodium channels.
Wanner SG; Glossmann H; Knaus HG; Baker R; Parsons W; Rupprecht KM; Brochu R; Cohen CJ; Schmalhofer W; Smith M; Warren V; Garcia ML; Kaczorowski GJ
Biochemistry; 1999 Aug; 38(34):11137-46. PubMed ID: 10460170
[TBL] [Abstract][Full Text] [Related]
2. Specific binding of the novel Na+ channel blocker PD85,639 to the alpha subunit of rat brain Na+ channels.
Thomsen W; Hays SJ; Hicks JL; Schwarz RD; Catterall WA
Mol Pharmacol; 1993 Jun; 43(6):955-64. PubMed ID: 8391120
[TBL] [Abstract][Full Text] [Related]
3. High affinity interaction of mibefradil with voltage-gated calcium and sodium channels.
Eller P; Berjukov S; Wanner S; Huber I; Hering S; Knaus HG; Toth G; Kimball SD; Striessnig J
Br J Pharmacol; 2000 Jun; 130(3):669-77. PubMed ID: 10821797
[TBL] [Abstract][Full Text] [Related]
4. Margatoxin binds to a homomultimer of K(V)1.3 channels in Jurkat cells. Comparison with K(V)1.3 expressed in CHO cells.
Helms LM; Felix JP; Bugianesi RM; Garcia ML; Stevens S; Leonard RJ; Knaus HG; Koch R; Wanner SG; Kaczorowski GJ; Slaughter RS
Biochemistry; 1997 Mar; 36(12):3737-44. PubMed ID: 9132027
[TBL] [Abstract][Full Text] [Related]
5. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
[TBL] [Abstract][Full Text] [Related]
6. A novel drug binding site on voltage-gated sodium channels in rat brain.
Riddall DR; Leach MJ; Garthwaite J
Mol Pharmacol; 2006 Jan; 69(1):278-87. PubMed ID: 16219909
[TBL] [Abstract][Full Text] [Related]
7. High-affinity blockade of voltage-operated skeletal muscle sodium channels by 2,6-dimethyl-4-chlorophenol.
Haeseler G; Gudehus S; Bufler J; Dengler R; Leuwer M
Eur J Anaesthesiol; 2006 Mar; 23(3):190-6. PubMed ID: 16430789
[TBL] [Abstract][Full Text] [Related]
8. Voltage- and frequency-dependent pentobarbital suppression of brain and muscle sodium channels expressed in a mammalian cell line.
Rehberg B; Bennett E; Xiao YH; Levinson SR; Duch DS
Mol Pharmacol; 1995 Jul; 48(1):89-97. PubMed ID: 7623779
[TBL] [Abstract][Full Text] [Related]
9. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits.
Mourre C; Chernova MN; Martin-Eauclaire MF; Bessone R; Jacquet G; Gola M; Alper SL; Crest M
J Pharmacol Exp Ther; 1999 Dec; 291(3):943-52. PubMed ID: 10565809
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7.
Williams BS; Felix JP; Priest BT; Brochu RM; Dai K; Hoyt SB; London C; Tang YS; Duffy JL; Parsons WH; Kaczorowski GJ; Garcia ML
Biochemistry; 2007 Dec; 46(50):14693-703. PubMed ID: 18027973
[TBL] [Abstract][Full Text] [Related]
11. Four novel tarantula toxins as selective modulators of voltage-gated sodium channel subtypes.
Bosmans F; Rash L; Zhu S; Diochot S; Lazdunski M; Escoubas P; Tytgat J
Mol Pharmacol; 2006 Feb; 69(2):419-29. PubMed ID: 16267209
[TBL] [Abstract][Full Text] [Related]
12. Di-substituted cyclohexyl derivatives bind to two identical sites with positive cooperativity on the voltage-gated potassium channel, K(v)1.3.
Schmalhofer WA; Slaughter RS; Matyskiela M; Felix JP; Tang YS; Rupprecht K; Kaczorowski GJ; Garcia ML
Biochemistry; 2003 Apr; 42(16):4733-43. PubMed ID: 12705837
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
Jäger H; Grissmer S
Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
[TBL] [Abstract][Full Text] [Related]
14. Binding properties of (3)H-PbTx-3 and (3)H-saxitoxin to brain membranes and to skeletal muscle membranes of puffer fish Fugu pardalis and the primary structure of a voltage-gated Na(+) channel alpha-subunit (fMNa1) from skeletal muscle of F. pardalis.
Yotsu-Yamashita M; Nishimori K; Nitanai Y; Isemura M; Sugimoto A; Yasumoto T
Biochem Biophys Res Commun; 2000 Jan; 267(1):403-12. PubMed ID: 10623632
[TBL] [Abstract][Full Text] [Related]
15. [3H]Phenytoin identifies a novel anticonvulsant-binding domain on voltage-dependent sodium channels.
Francis J; Burnham WM
Mol Pharmacol; 1992 Dec; 42(6):1097-103. PubMed ID: 1336115
[TBL] [Abstract][Full Text] [Related]
16. Substitution of a single residue in Stichodactyla helianthus peptide, ShK-Dap22, reveals a novel pharmacological profile.
Middleton RE; Sanchez M; Linde AR; Bugianesi RM; Dai G; Felix JP; Koprak SL; Staruch MJ; Bruguera M; Cox R; Ghosh A; Hwang J; Jones S; Kohler M; Slaughter RS; McManus OB; Kaczorowski GJ; Garcia ML
Biochemistry; 2003 Nov; 42(46):13698-707. PubMed ID: 14622016
[TBL] [Abstract][Full Text] [Related]
17. Role for Pro-13 in directing high-affinity binding of anthopleurin B to the voltage-sensitive sodium channel.
Kelso GJ; Drum CL; Hanck DA; Blumenthal KM
Biochemistry; 1996 Nov; 35(45):14157-64. PubMed ID: 8916901
[TBL] [Abstract][Full Text] [Related]
18. [3H]linopirdine binding to rat brain membranes is not relevant for M-channel interaction.
Wolff C; Gillard M; Fuks B; Chatelain P
Eur J Pharmacol; 2005 Jul; 518(1):10-7. PubMed ID: 16018996
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D(2) receptor modulation of K(+) channel activity regulates excitability of nucleus accumbens neurons at different membrane potentials.
Perez MF; White FJ; Hu XT
J Neurophysiol; 2006 Nov; 96(5):2217-28. PubMed ID: 16885524
[TBL] [Abstract][Full Text] [Related]
20. WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes.
Hill RJ; Grant AM; Volberg W; Rapp L; Faltynek C; Miller D; Pagani K; Baizman E; Wang S; Guiles JW
Mol Pharmacol; 1995 Jul; 48(1):98-104. PubMed ID: 7542739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
